Last reviewed · How we verify
NCT04471220
Exercise Capacity Under Various FiO2 and Oxygen Flow Rates Using HFNC
NA trial testing High-flow nasal cannula in High-flow Nasal Cannula in 50 participants. Completed in 29 September 2022.
29 September 2022
Quick facts
| Lead sponsor | National Hospital Organization Minami Kyoto Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | other |
| Enrollment | 50 |
| Start date | 1 July 2020 |
| Primary completion | 29 September 2022 |
| Estimated completion | 29 September 2022 |
| Sites | 1 location across Japan |
Drugs / interventions tested
- High-flow nasal cannula
Conditions studied
- High-flow Nasal Cannula — all drugs for High-flow Nasal Cannula →
- Exercise Capacity — all drugs for Exercise Capacity →
- Respiratory Failure — all drugs for Respiratory Failure →
Sponsor
National Hospital Organization Minami Kyoto Hospital
Who can join
Adults 20 to 90, any sex, with High-flow Nasal Cannula or Exercise Capacity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to compare the exercise capacity (6-min walking distance) under the following 4 conditions using High-flow nasal cannula (HFNC); 1. FIO2 value that the minimum SpO2 value in a 6-minute walking test (6MWT) is 86-88%, and a flow of 10 L/min 2. FIO2 value that the minimum SpO2 value in a 6MWT is 86-88%, and a flow of 40-50 L/min 3. FIO2 value that the minimum SpO2 value in a 6MWT is 92-94%, and a flow of 10 L/min 4. FIO2 value that the minimum SpO2 value in a 6MWT is 92-94%, and a flow of 40-50 L/min
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04471220
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High-flow nasal cannula
Trials testing the same drug.
- NCT07155330 — High-flow Nasal Cannula Oxygenation in Sedated Endoscopy for High-risk Obstructive Sleep Apnea Patients · NA · completed
- NCT06663293 — Comparison of High Flow vs Standard Nasal Cannula in Children With Burns Under Sedoanalgesia · NA · completed
- NCT05012696 — Physiological Effects of Non-invasive Mechanical Ventilation Versus High-flow Nasal Cannula in Critically Ill Patients a · NA · completed
- NCT04507425 — High Flow Nasal Cannula With Noninvasive Ventilation · NA · completed
- NCT04353531 — Investigate the Aerosol Particle Distribution During Aerosol Generating Procedures · completed
Other recruiting trials for High-flow Nasal Cannula
Currently open trials in the same condition.
- NCT06425406 — Application of HFNC for the Prevention of Hypoxemia During Perioperative Anesthetic-induced Intubation in Children: A Ra · NA · recruiting
- NCT06879600 — High-Flow Nasal Oxygen for Preoxygenation in Emergency Surgery Patients With Full Stomachs · NA · recruiting
- NCT06582459 — Efficacy and Safety of High-Flow Nasal Cannula Versus Noninvasive Ventilation for Pulmonary Arterial Hypertension-Associ · active not recruiting
- NCT05526534 — A RCT on the Preventive Effect of HFNC on Postoperative Pulmonary Complications in Patients With Gynecologic Neoplasms · NA · recruiting
- NCT06375538 — Ultrasound Evaluations of Diaphragm and Intercostal Muscle to Predict the Failure of High-Flow Nasal Cannula Therapy · recruiting
Other National Hospital Organization Minami Kyoto Hospital trials
Trials by the same sponsor.
- NCT04590391 — Visual and Auditory Breathing-swallowing Coordinated Training · NA · completed
- NCT03550820 — Energy Metabolism for the Patients With Pulmonary Mycobacterium Avium Complex · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04471220 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Hospital Organization Minami Kyoto Hospital
- Last refreshed: 30 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04471220.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing